Innovative Biomedicine · Technology Leads the Future
Discover UNIKEShape the Future Together
Dedicated to technological revolution and better medicines, safeguarding human health.
Learn More
TECHNOLOGY PLATFORM
Technology Platforms
Innovation-driven, modular platforms for long-acting peptide and protein drug design and optimization
PRODUCT PIPELINE
Long-Acting Recombinant Protein Drugs Improving Patient Compliance
UNIKE has built multiple proprietary technology platforms supporting modular, efficient design of long-acting protein drug molecules. The company currently has over 20 innovative recombinant protein drugs under development.
- Rooted in source innovation of biologics, focusing on long-acting protein breakthroughs to build new solutions for disease treatment.
- Innovation-driven, modular design and optimization platform for long-acting peptides and proteins
ABOUT US
About UNIKE
To become the global birthplace of long-acting protein and peptide innovative drugs
UNIKE stands at the forefront of global biomedicine. With disruptive original technology at its core, the company brings together top global scientific and industrial talent, focusing on the premium track of long-acting protein and peptide innovative drugs. Addressing the industry's core pain points of poor druggability and difficult breakthroughs, and relying on the proprietary ZT technology platform, UNIKE focuses on innovative drug R&D for major diseases — committed to building a global hub for long-acting peptide innovation, filling unmet clinical needs, and safeguarding human health.
- Founded
- 2026
- Pipeline Programs
- 20+
- Core Platforms
- 5